King David John 4
4 · aTYR PHARMA INC · Filed Feb 8, 2018
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
King David John
See Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2018-02-06+150,000→ 150,000 totalExercise: $3.30Exp: 2028-02-06→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2018, such that this option will be fully exercisable on February 6, 2022. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.